Keywords: MC, mixed cryoglobulinemia; HCV, hepatitis C virus; SMZL, splenic marginal zone lymphoma; SVR, sustained virological response; PEG-IFN, pegylated interferon alpha; DAA, direct-acting antiviral; BVAS, Birmingham Vasculitis Activity Score; CR, complete resp
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: HCV, hepatitis C virus; DAA, direct-acting antiviral; TPV, telaprevir; BOC, boceprevir; SMV, simeprevir; SOF, sofosbuvir; DSV, dasabuvir; LDV, ledipasvir; DCV, daclatasvir; OBV, ombitasvir; GT, genotype; RBV, ribavirin; PI, protease inhibitor; PTV/r, pari
HCV epidemiology in high-risk groups and the risk of reinfection
Keywords: PWID, people who inject drugs; MSM, men who have sex with men; HCV, hepatitis C virus; IDU, injecting drug use; DAA, direct-acting antiviral; PY, person-years; NSP, needle/syringe provision; OST, opioid substitution treatment; HIV, human immunodeficiency
Entry inhibitors and future treatment of hepatitis C
Keywords: CLDN1, claudin-1; DAA, direct-acting antiviral; HCV, hepatitis C virus; OCLN, occludin; SR-BI, scavenger receptor class B type I; TfR1, transferrin receptor; PS-ON, phosphorothioate oligonucleotides; PEG-IFN-α, pegylated interferon-α; RBV, ribavirinEntry
Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents
Keywords: Chronic hepatitis C; Direct-acting antivirals; Host-targeting antivirals; Interferon; Protease inhibitors; RibavirinBOC, boceprevir; CHC, chronic hepatitis C; CV, cryoglobulinemic vasculitis; DAA, direct-acting antiviral; DVR, delayed virological response
Treating hepatitis C infection by targeting the host
Keywords: apo, apolipoprotein; CLDN1, claudin-1; CsA, cyclosporine A; CyPA, cyclophilin A; DAA, direct-acting antiviral; EGFR, epidermal growth factor receptor; ER, endoplasmic reticulum; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; LD, lipid droplet; MTP
C-6 aryl substituted 4-quinolone-3-carboxylic acids as inhibitors of hepatitis C virus
Keywords: HIV, human immunodeficiency virus; IN, integrase; HCV, hepatitis C virus; SOC, standard of care; peg-INF, peglylated interferon; RBV, ribavirin; SVR, sustained virological response; DAA, direct-acting antiviral; NNI, non-nucleoside inhibitor; EVG, elviteg